Loading people...
Albert Cha is a Managing Partner at Frazier Healthcare Partners in Seattle, Washington, where he co-leads the firm's Life Sciences team and its public fund. Before joining Frazier in 2021, he spent over two decades as a Managing Partner at Vivo Capital, investing across both public and private biopharmaceutical markets. He currently serves as Chairman of the board for Ascendis Pharma and holds a director position at KalVista Pharmaceuticals, following previous board roles at Biohaven Pharmaceuticals and Sierra Oncology. Earlier in his career, he worked in pharmaceutical consulting at Oracle Corporation and earned his medical degree and a doctorate in neuroscience from the UCLA School of Medicine, alongside engineering degrees from Stanford University. Cha focuses his current investments on scaling therapeutic startups and medical device companies through major funding rounds and public market exits.
Albert Cha stands as a distinguished Managing Partner at Frazier Healthcare Partners, a premier private equity and venture capital firm exclusively dedicated to the healthcare industry. With a career marked by strategic insight and a deep understanding of the life sciences, Cha plays a pivotal role in identifying, funding, and nurturing groundbreaking companies that aim to transform patient care.
At Frazier Healthcare Partners, Albert Cha's investment focus is sharply honed on venture opportunities within the biopharmaceutical and medical device sectors. He is particularly adept at partnering with entrepreneurs to form and build companies from their inception, leveraging his extensive network and operational experience. His portfolio typically includes early-stage and growth-stage companies developing novel therapeutics, diagnostics, and medical technologies designed to address significant unmet medical needs. Cha's approach emphasizes rigorous scientific evaluation combined with a keen eye for market potential and strategic execution.
Cha's impressive career trajectory before joining Frazier in 2003 provided him with a robust foundation in both science and business. He earned his M.D. from Stanford University School of Medicine and a B.S. in Biological Sciences from Stanford University, equipping him with a strong scientific background crucial for evaluating complex healthcare innovations. Prior to his tenure at Frazier, Cha served as a Principal at Advanced Technology Ventures (ATV), where he concentrated on life science investments. His earlier professional experience also includes a role at the Boston Consulting Group, where he honed his strategic consulting skills across various industries, further broadening his business acumen.
Throughout his career, Albert Cha has been instrumental in the success of numerous portfolio companies, often serving on their boards of directors to guide their growth and strategic direction. While specific investment details are proprietary, his involvement has been critical in companies that have achieved significant milestones, including successful clinical development, strategic partnerships, and lucrative acquisitions. His leadership has contributed to the development of innovative solutions in areas ranging from oncology and immunology to cardiovascular health and neurological disorders.
Albert Cha's commitment to advancing healthcare through strategic investment and company building makes him a highly influential figure in the venture capital landscape. His blend of medical expertise, business acumen, and a proven track record of success continues to drive innovation and create value within the dynamic healthcare industry, solidifying Frazier Healthcare Partners' position as a leader in the field.
Albert Cha is a highly respected Managing Partner at Frazier Healthcare Partners, a leading healthcare-focused venture capital firm. He is known for his expertise in identifying and nurturing innovative companies within the biopharmaceutical and medical device sectors.
Albert Cha primarily invests in early-stage and growth-stage biopharmaceutical and medical device companies. His focus is on venture investments that aim to develop groundbreaking therapies and technologies to address significant unmet medical needs.
Albert Cha works at Frazier Healthcare Partners, a prominent private equity and venture capital firm dedicated exclusively to the healthcare industry. He is based at their offices, contributing to their extensive portfolio of healthcare investments.
